The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
Radical cystectomy with extended pelvic lymph node dissection is the gold standard for the treatment of muscle-invasive bladder cancer (MIBC). Despite this definitive surgery, patients face a recurrence rate of approximately 50% 5 years after surgery. This high recurrence rate may be related to micr...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2016-04-01
|
| Series: | European Medical Journal Urology |
| Subjects: | |
| Online Access: | http://emjreviews.com/wp-content/uploads/The-Current-State-of-Neoadjuvant-Chemotherapy-for-Muscle-Invasive-Bladder-Cancer.pdf |